Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Dr Reddys Laboratories (RDY) over the last 15 years, with Q3 2025 value amounting to $2.1 billion.

  • Dr Reddys Laboratories' Total Liabilities rose 1024.81% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 1024.81%. This contributed to the annual value of $1.8 billion for FY2025, which is 4213.4% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Total Liabilities stood at $2.1 billion for Q3 2025, which was up 1024.81% from $1.8 billion recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Total Liabilities peaked at $2.1 billion during Q3 2025, and registered a low of $1.1 billion during Q3 2022.
  • Moreover, its 5-year median value for Total Liabilities was $1.3 billion (2021), whereas its average is $1.4 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 1875.5% in 2023, then soared by 6461.33% in 2024.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Total Liabilities stood at $1.3 billion in 2021, then fell by 16.72% to $1.1 billion in 2022, then increased by 6.9% to $1.1 billion in 2023, then soared by 64.61% to $1.9 billion in 2024, then grew by 10.25% to $2.1 billion in 2025.
  • Its Total Liabilities stands at $2.1 billion for Q3 2025, versus $1.8 billion for Q1 2025 and $1.9 billion for Q3 2024.